Sponsor Pipeline

Ganzhou Hemay Pharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
4
Recruiting
2
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06145893 A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease Behçet's Disease Recruiting
NCT07650942 Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis (UC) Not Yet Recruiting
Phase 2
NCT07314242 A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to… COPD (Chronic Obstructive Pulmonary Disease) Not Yet Recruiting
NCT05486104 Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis Moderate to Severe Ulcerative Colitis Active, Not Recruiting
Phase 1
NCT05749432 A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors Solid Tumor Recruiting
NCT06376474 To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage Psoriasis Recruiting
NCT07446816 A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181 Advanced Solid Tumors Recruiting
NCT07624864 A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients… Solid Tumors Not Yet Recruiting
Disease Areas
Get alerts when Ganzhou Hemay Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free